celecoxib and nimesulide

celecoxib has been researched along with nimesulide in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.64)	18.2507
2000's	39 (63.93)	29.6817
2010's	20 (32.79)	24.3611
2020's	1 (1.64)	2.80

Authors

Authors	Studies
Damas, J; de Leval, X; Dogné, JM; Julémont, F; Michaux, C; Montero, JL; Pirotte, B; Renard, JF; Winum, JY	1
Caciagli, B; Carotti, S; Chiricosta, G; Landini, I; Maccari, R; Mini, E; Ottanà, R; Vigorita, MG	1
Arslan, D; de Leval, X; Garbacki, N; Pirotte, B; Renard, JF	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, SH; Gu, LQ; Huang, ZS; Li, D; Li, Y; Ou, TM; Tan, JH	1
Meanwell, NA	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
de Leval, X; Hubert, P; Lecomte, F; Pirotte, B; Renard, JF	1
Singh, P; Tewari, AK; Yadav, P	1
Arai, J; Hisa, T; Maeda, M; Mukai, T; Ohkubo, Y; Ohshima, T; Saito, Y; Yamamoto, F; Yamamoto, Y	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF	1
Wallace, JL	1
Hawkey, CJ; Jackson, LM	1
Cairns, SR; O'Beirne, JP	1
Mejza, F; Nizankowska, E	1
Friel, AM; Healy, DG; Morrison, JJ; Slattery, MM	1
Kawamori, T; Wakabayashi, K	1
Bianchi, M; Broggini, M	2
Malhotra, S; Pandhi, P; Shafiq, N	2
Devière, J	1
Gazi, MH; Pan, Y; Young, CY; Zhang, JS	1
Bhatia, S; Seedher, N	1
Chen, PY; Long, QC	1
Benoit, V; de Leval, X; Dogné, JM; Frederich, M; Julémont, F; Pirotte, B	1
Meena, S; Nagaraju, D; Rao, AR; Rao, RN	1
Canonica, GW; D'Amato, G; Liccardi, G; Lobefalo, G; Noschese, P; Passalacqua, G; Piccolo, A; Salzillo, A	1
D'Amato, G; D'Amato, M; Liccardi, G; Piccolo, A; Piscitelli, E; Salzillo, A; Senna, G	1
Meena, S; Nageswara Rao, R; Raghuram Rao, A	1
Mullangi, R; Pavan Kumar, VV; Ramani, AV; Srinivas, NR; Vinu, MC	1
Malhotra, S; Nada, R; Pandhi, P; Shafiq, N	1
Arakawa, T; Fujiwara, Y; Hamaguchi, M; Hayakawa, T; Higuchi, K; Okuyama, M; Oshitani, N; Sasaki, E; Sugawa, T; Tominaga, K; Watanabe, T	1
Fraunfelder, FW; Mehelas, TJ; Solomon, J	1
Kandefer-Szerszeń, M; Majdan, M; Parada-Turska, J; Rzeski, W; Turski, WA	1
Arana, A; Castellsague, J; Perez-Gutthann, S; Sanchez-Matienzo, D	1
Bagcivan, I; Cetin, A; Gulturk, S; Gursoy, S; Karadas, B; Kaya, T; Parlak, A	1
Ballmer-Weber, BK; Hofbauer, G; Roll, A; Schmid-Grendelmeier, P; Wüthrich, B	1
Becker, TL; Gambero, A; Maróstica, M; Pedrazzoli, J	1
Nikitakis, NG; Sauk, JJ; Scheper, MA	1
Balzarini, P; Bianchi, M; Broggini, M; Franchi, S; Sacerdote, P	1
Dastis, SN; Geubel, AP; Lerut, J; Rahier, J	1
Buyse, M; Farinotti, R; Zrieki, A	1
Han, JA; Kim, SR; Lee, ME; Park, JH; Park, JS; Park, SC	1
Chan, PC; Chen, CH; Chiang, CF; Hsieh, PS; Jin, JS; Shih, KC	1
King, RS; Struzik, SM; Yalcin, EB	1
Clapper, ML; Foreman, JE; Gonzalez, FJ; McGinnis, KS; Peters, JM; Rigas, B; Sorg, JM; Williams, JL	1
Dolezal, T; Krsiak, M; Sliva, J; Sykora, D; Vosmanska, M	1
Chen, CH; Chiang, CF; Hsieh, PS; Lu, KC	1
Cetin, A; Cetin, M; Guvenal, T; Timuroglu, Y; Yanar, O	1
Chen, CH; Hsia, TL; Hsieh, CH; Hsieh, PS; Huang, DW; Tian, YF	1
Cerella, C; Chateauvieux, S; Dicato, M; Diederich, M; Ghelfi, J; Henry, E; Schnekenburger, M; Sobolewski, C	1
Cerella, C; Dicato, M; Diederich, M; Sobolewski, C	1
Gaur, V; Kumar, A	1
Ahmed, S; Ercisli, S; Gul, H; Gul, S; Zia-Ul-Haq, M	1
Aujla, U; Bjarnason, I; Kvasnovsky, CL	1
Ahmed, S; Gul, S; Riaz, M; Zia-ul-Haq, M	1
Davydkin, IL; Zolotovskaia, IA	1
Çakmak, ME	1

Reviews

9 review(s) available for celecoxib and nimesulide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Recently reported biological activities of pyrazole compounds. Bioorganic & medicinal chemistry, 2017, 11-01, Volume: 25, Issue:21 Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles	2017
Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs). The American journal of medicine, 1999, Dec-13, Volume: 107, Issue:6A Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etodolac; Gene Expression; Humans; Ibuprofen; Indomethacin; Isoenzymes; Meloxicam; Membrane Proteins; Naproxen; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles	1999
COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages? Drugs, 2000, Volume: 59, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Etodolac; Humans; Lactones; Meloxicam; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2000
[Selective cyclooxygenase 2 inhibitors (COX-2)]. Postepy higieny i medycyny doswiadczalnej, 2001, Volume: 55, Issue:2 Topics: Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Inflammation; Isoenzymes; Lactones; Meloxicam; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Protein Isoforms; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2001
Do selective cyclo-oxygenase inhibitors eliminate the adverse events associated with nonsteroidal anti-inflammatory drug therapy? European journal of gastroenterology & hepatology, 2002, Volume: 14 Suppl 1 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Meloxicam; Neoplasms; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2002
First and second generations of COX-2 selective inhibitors. Mini reviews in medicinal chemistry, 2004, Volume: 4, Issue:6 Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etoricoxib; Gastrointestinal Diseases; Humans; Isoenzymes; Isoxazoles; Lactones; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyridines; Sulfonamides; Sulfones	2004
An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. Journal of pharmaceutical and biomedical analysis, 2005, Sep-15, Volume: 39, Issue:3-4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Industry; Etodolac; Etoricoxib; Lactones; Models, Chemical; Pyrazoles; Pyridines; Spectrophotometry; Sulfonamides; Sulfones; Ultraviolet Rays	2005
Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease. Scandinavian journal of gastroenterology, 2015, Volume: 50, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Gastrointestinal Tract; Humans; Inflammatory Bowel Diseases; Observational Studies as Topic; Pain; Pyrazoles; Pyridines; Recurrence; Sulfonamides; Sulfones	2015

Trials

7 trial(s) available for celecoxib and nimesulide

Article	Year
Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstetrics and gynecology, 2001, Volume: 98, Issue:4 Topics: Adult; Celecoxib; Cesarean Section; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Hysterectomy; Isoenzymes; Labor, Obstetric; Meloxicam; Membrane Proteins; Middle Aged; Myometrium; Pregnancy; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles; Uterine Contraction	2001
Anti-hyperalgesic effects of nimesulide: studies in rats and humans. International journal of clinical practice. Supplement, 2002, Issue:128 Topics: Aged; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Diclofenac; Double-Blind Method; Female; Humans; Hyperalgesia; Lactones; Male; Middle Aged; Models, Animal; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Sulfones	2002
A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. Drugs, 2003, Volume: 63 Suppl 1 Topics: Adult; Aged; Analysis of Variance; Celecoxib; Double-Blind Method; Female; Humans; Knee; Lactones; Male; Middle Aged; Osteoarthritis; Osteoarthritis, Knee; Pain; Pain Measurement; Pyrazoles; Sulfonamides; Sulfones; Time Factors	2003
Safety of celecoxib in patients with adverse reactions to nimesulide. Allergy, 2005, Volume: 60, Issue:5 Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Hypersensitivity; Erythema; Female; Humans; Male; Middle Aged; Pyrazoles; Single-Blind Method; Sulfonamides; Urticaria	2005
Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs. European annals of allergy and clinical immunology, 2005, Volume: 37, Issue:2 Topics: Acetaminophen; Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Immunologic; Drug Combinations; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Immediate; Male; Middle Aged; Pyrazoles; Single-Blind Method; Skin Tests; Sulfonamides	2005
Tolerance to celecoxib in patients with a history of adverse reactions to nonsteroidal anti-inflammatory drugs. Swiss medical weekly, 2006, Oct-28, Volume: 136, Issue:43-44 Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrazoles; Single-Blind Method; Sulfonamides	2006
Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. International journal of clinical practice, 2007, Volume: 61, Issue:8 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Celecoxib; Double-Blind Method; Female; Humans; Interleukin-6; Interleukin-8; Male; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Substance P; Sulfonamides; Synovial Fluid; Treatment Outcome	2007

Other Studies

45 other study(ies) available for celecoxib and nimesulide

Article	Year
Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors. Journal of medicinal chemistry, 2004, Dec-30, Volume: 47, Issue:27 Topics: Crystallography, X-Ray; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Design; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyridines; Structure-Activity Relationship; Sulfonamides	2004
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Thiazolidinediones	2005
Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors. Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Design; Humans; Pleurisy; Pyrazoles; Pyridines; Rats; Sulfonamides	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase. Bioorganic & medicinal chemistry, 2011, Mar-15, Volume: 19, Issue:6 Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Benzoates; Binding Sites; Computer Simulation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Lipoxygenase Inhibitors; Structure-Activity Relationship; Sulfonamides	2011
Synopsis of some recent tactical application of bioisosteres in drug design. Journal of medicinal chemistry, 2011, Apr-28, Volume: 54, Issue:8 Topics: Cytochrome P-450 Enzyme System; Drug Design	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism. European journal of medicinal chemistry, 2014, Mar-03, Volume: 74 Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase Inhibitors; Magnetic Resonance Spectroscopy; Pyridines; Rats; Sulfonamides	2014
Design, synthesis, docking and anti-inflammatory evaluation of novel series of benzofuran based prodrugs. Bioorganic & medicinal chemistry letters, 2014, May-15, Volume: 24, Issue:10 Topics: Animals; Anti-Inflammatory Agents; Benzofurans; Crystallography, X-Ray; Drug Design; Models, Molecular; Molecular Docking Simulation; Prodrugs; Rats	2014
Isomeric methoxy analogs of nimesulide for development of brain cyclooxygense-2 (COX-2)-targeted imaging agents: Synthesis, in vitro COX-2-inhibitory potency, and cellular transport properties. Bioorganic & medicinal chemistry, 2015, Nov-01, Volume: 23, Issue:21 Topics: Brain; Caco-2 Cells; Catalytic Domain; Contrast Media; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Isomerism; Molecular Conformation; Molecular Dynamics Simulation; Protein Binding; Sulfonamides	2015
Drug Points: Cholestatic hepatitis in association with celecoxib. BMJ (Clinical research ed.), 2001, Jul-07, Volume: 323, Issue:7303 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Cyclooxygenase Inhibitors; Female; Humans; Middle Aged; Pyrazoles; Sulfonamides	2001
COX-2 and prostanoid receptors: good targets for chemoprevention. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2002, Volume: 21, Issue:2 Topics: Animals; Breast Neoplasms; Celecoxib; Cell Transformation, Neoplastic; Chemoprevention; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Female; Humans; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Sulfonamides	2002
Effect of cyclooxygenase inhibitors in postoperative ileus: an experimental study. Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:5 Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Indomethacin; Intestinal Obstruction; Male; Postoperative Complications; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides	2002
The cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs celecoxib and nimesulide inhibit androgen receptor activity via induction of c-Jun in prostate cancer cells. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2003, Volume: 12, Issue:8 Topics: Androgen Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Blotting, Western; Celecoxib; Gene Expression; Genes, jun; Humans; Male; Phosphorylation; Prostatic Neoplasms; Pyrazoles; Sulfonamides; Tacrolimus Binding Proteins; Transfection; Tumor Cells, Cultured	2003
Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS PharmSciTech, 2003, Volume: 4, Issue:3 Topics: Celecoxib; Chemistry, Pharmaceutical; Cyclooxygenase 2; Enzyme Inhibitors; Hydrogen-Ion Concentration; Isoenzymes; Lactones; Meloxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Solubility; Solvents; Sulfonamides; Sulfones; Thiazines; Thiazoles	2003
Comparison of nonselective cyclo-oxygenase (COX) inhibitor and selective COX-2 inhibitors on preimplantation loss, postimplantation loss and duration of gestation: an experimental study. Contraception, 2004, Volume: 69, Issue:1 Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Embryonic Development; Female; Gestational Age; Indomethacin; Pregnancy; Pyrazoles; Rats; Rats, Wistar; Sulfonamides	2004
Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells. Acta pharmacologica Sinica, 2004, Volume: 25, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Cycle; Cell Line, Tumor; Chick Embryo; Chorion; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Fragmentation; Humans; Isoenzymes; Membrane Proteins; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides	2004
Development and validation of a reversed-phase liquid chromatographic method for separation and simultaneous determination of COX-2 inhibitors in pharmaceuticals and its application to biological fluids. Biomedical chromatography : BMC, 2005, Volume: 19, Issue:5 Topics: Butanones; Celecoxib; Chromatography, Liquid; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Lactones; Nabumetone; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Sulfones	2005
Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection. Biomedical chromatography : BMC, 2006, Volume: 20, Issue:1 Topics: Animals; Celecoxib; Chromatography, High Pressure Liquid; Etoricoxib; Humans; Isoxazoles; Ketoprofen; Male; Pyrazoles; Pyridines; Rats; Rats, Wistar; Reproducibility of Results; Salicylic Acid; Spectrophotometry, Ultraviolet; Sulfonamides; Sulfones	2006
Comparative gastrointestinal toxicity of selective cyclooxygenase (COX-2) inhibitors. Indian journal of experimental biology, 2005, Volume: 43, Issue:7 Topics: Animals; Celecoxib; Colitis; Cyclooxygenase Inhibitors; Gastric Mucosa; Gastrointestinal Tract; Indomethacin; Male; Pyrazoles; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides	2005
Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis. Gut, 2006, Volume: 55, Issue:4 Topics: Animals; Celecoxib; Cell Division; Chronic Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytosol; Dinoprostone; Epithelial Cells; Esophagitis, Peptic; Esophagus; Immunohistochemistry; Intramolecular Oxidoreductases; Male; Microsomes; Prostaglandin-E Synthases; Pyrazoles; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides	2006
Ocular adverse effects associated with cyclooxygenase-2 inhibitors. Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:2 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Celecoxib; Conjunctivitis; Cyclooxygenase 2 Inhibitors; Etodolac; Humans; Isoxazoles; Lactones; Middle Aged; Pyrazoles; Sulfonamides; Sulfones; Vision Disorders	2006
Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro. European journal of pharmacology, 2006, Mar-27, Volume: 535, Issue:1-3 Topics: Animals; Antirheumatic Agents; Benzodiazepines; Benzodiazepinones; Celecoxib; Cell Line; Cell Proliferation; Cell Survival; Diclofenac; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Inhibitory Concentration 50; Methotrexate; Naproxen; Pyrazoles; Quinoxalines; Sulfasalazine; Sulfonamides; Synovial Membrane	2006
Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. Clinical therapeutics, 2006, Volume: 28, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Celecoxib; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2 Inhibitors; Humans; Lactones; Odds Ratio; Pyrazoles; Safety; Sulfonamides; Sulfones; Sulindac	2006
Additive interaction of intraperitoneal dexmedetomidine and topical nimesulide, celecoxib, and DFU for antinociception. European journal of pharmacology, 2007, Feb-05, Volume: 556, Issue:1-3 Topics: Administration, Topical; Adrenergic alpha-Agonists; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Dexmedetomidine; Drug Administration Routes; Drug Synergism; Furans; Injections, Intraperitoneal; Male; Pain; Pain Measurement; Pyrazoles; Rats; Rats, Wistar; Sulfonamides	2007
Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol. Digestive diseases and sciences, 2007, Volume: 52, Issue:2 Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytoprotection; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Gastric Acid; Gastric Mucosa; Ibuprofen; Irritants; Male; Meloxicam; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Sulfonamides; Thiazines; Thiazoles	2007
Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. International journal of oral and maxillofacial surgery, 2007, Volume: 36, Issue:7 Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2 Inhibitors; Cysteine Proteinase Inhibitors; Down-Regulation; Enzyme Inhibitors; Humans; Immunohistochemistry; Indomethacin; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Pyrazoles; Signal Transduction; STAT3 Transcription Factor; Sulfonamides; Sulindac; Survivin; Tongue Neoplasms; Tumor Cells, Cultured	2007
Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:11 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Failure, Acute; Liver Transplantation; Middle Aged; Piroxicam; Pyrazoles; Sulfonamides	2007
Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharmaceutical research, 2008, Volume: 25, Issue:9 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Celecoxib; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Indomethacin; Naproxen; Neoplasm Proteins; Pyrazoles; Reproducibility of Results; RNA, Messenger; Sulfonamides; Time Factors	2008
Selective COX-2 inhibitors modulate cellular senescence in human dermal fibroblasts in a catalytic activity-independent manner. Mechanisms of ageing and development, 2008, Volume: 129, Issue:12 Topics: Aspirin; Caveolin 1; Celecoxib; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Fibroblasts; Flurbiprofen; Humans; Ibuprofen; Kinetics; Models, Biological; NF-kappa B; Nitrobenzenes; Pyrazoles; Reactive Oxygen Species; Skin; Skin Aging; Sulfonamides; Tumor Suppressor Protein p53	2008
COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring, Md.), 2009, Volume: 17, Issue:6 Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Blood Glucose; Body Weight; Celecoxib; Cell Size; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprost; Disease Models, Animal; Fatty Liver; Insulin; Insulin Resistance; Leptin; Liver; Macrophages; Male; Membrane Proteins; Obesity; Panniculitis; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Triglycerides; Tumor Necrosis Factor-alpha	2009
Allosteric modulation of SULT2A1 by celecoxib and nimesulide: computational analyses. Drug metabolism letters, 2008, Volume: 2, Issue:3 Topics: Allosteric Regulation; Binding Sites; Celecoxib; Drug Interactions; Estradiol; Humans; Ligands; Protein Binding; Protein Conformation; Pyrazoles; Software; Sulfonamides; Sulfotransferases	2008
Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs. Molecular carcinogenesis, 2009, Volume: 48, Issue:10 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Blotting, Western; Celecoxib; Colonic Neoplasms; Colonic Polyps; Disease Models, Animal; Female; Genes, APC; Humans; Indomethacin; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrobenzenes; PPAR delta; PPAR-beta; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sulfonamides; Tumor Cells, Cultured	2009
Guaifenesin enhances the analgesic potency of ibuprofen, nimesulide and celecoxib in mice. Neuro endocrinology letters, 2009, Volume: 30, Issue:3 Topics: Acetic Acid; Analgesia; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Synergism; Expectorants; Guaifenesin; Ibuprofen; Male; Mice; Pain; Pain Measurement; Pyrazoles; Sulfonamides	2009
Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats. European journal of clinical investigation, 2010, Volume: 40, Issue:2 Topics: Adiposity; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Glucose; Blood Pressure; Celecoxib; Chemokine CCL2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Fats; Glucose Tolerance Test; Immunohistochemistry; Inflammation; Insulin; Intra-Abdominal Fat; Obesity; Polymerase Chain Reaction; Pyrazoles; Rats; Rats, Sprague-Dawley; Subcutaneous Fat, Abdominal; Sulfonamides; Triglycerides; Tumor Necrosis Factor-alpha	2010
Effects of selective and non-selective cyclooxygenase (COX) inhibitors on postoperative adhesion formation in a rat uterine horn model. Clinical and experimental obstetrics & gynecology, 2010, Volume: 37, Issue:1 Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Female; Indomethacin; Postoperative Complications; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Tissue Adhesions; Uterus	2010
The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in high-fat-fed rats. Life sciences, 2011, Jul-18, Volume: 89, Issue:3-4 Topics: Adipose Tissue; Animals; Biomarkers; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diet, Reducing; Dietary Fats; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Obesity; Oxidative Stress; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides	2011
COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells. Biochemical pharmacology, 2011, Nov-15, Volume: 82, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; DNA Damage; Dose-Response Relationship, Drug; Hematologic Neoplasms; Humans; K562 Cells; Nitrobenzenes; Pyrazoles; Signal Transduction; Stress, Physiological; Sulfonamides; U937 Cells	2011
Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells. Cell cycle (Georgetown, Tex.), 2011, Sep-01, Volume: 10, Issue:17 Topics: Antigens, Differentiation; Apoptosis; Biomarkers; Celecoxib; Cell Differentiation; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Down-Regulation; Gene Expression Regulation, Leukemic; Humans; Interphase; Jurkat Cells; K562 Cells; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myc; Pyrazoles; Sulfonamides; U937 Cells; Up-Regulation	2011
Effect of nonselective and selective COX-2 inhibitors on memory dysfunction, glutathione system, and tumor necrosis factor alpha level against cerebral ischemia reperfusion injury. Drug and chemical toxicology, 2012, Volume: 35, Issue:2 Topics: Acetylcholinesterase; Animals; Behavior, Animal; Celecoxib; Cyclooxygenase 2 Inhibitors; Glutathione; Hippocampus; Ibuprofen; Male; Maze Learning; Memory Disorders; Pyrazoles; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides; Tumor Necrosis Factor-alpha	2012
Cyclooxygenase-2 inhibition improves antioxidative defense during experimental hypercholesterolemia. Bosnian journal of basic medical sciences, 2014, Volume: 14, Issue:2 Topics: Animals; Antioxidants; Celecoxib; Cholesterol, LDL; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Glutathione Peroxidase; Hypercholesterolemia; Male; Oxidative Stress; Pyrazoles; Rabbits; Sulfonamides; Superoxide Dismutase	2014
Hypolipidemic effects of nimesulide and celecoxib in experimentally induced hypercholesterolemia in rabbits. Turkish journal of medical sciences, 2015, Volume: 45, Issue:2 Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Diet, Atherogenic; Diet, High-Fat; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Pyrazoles; Rabbits; Sulfonamides; Treatment Outcome; Triglycerides	2015
[Cognitive-cytokine effect of nonsteroidal antiinflammatory drugs in the therapy of elderly patients with osteoarthritis]. Advances in gerontology = Uspekhi gerontologii, 2017, Volume: 30, Issue:3 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cognition; Cognition Disorders; Cytokines; Etoricoxib; Female; Humans; Interleukin-1beta; Interleukin-6; Male; Meloxicam; Osteoarthritis; Prospective Studies; Pyridines; Sulfonamides; Sulfones; Thiazines; Thiazoles; Transforming Growth Factor beta1	2017
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study. Tuberkuloz ve toraks, 2022, Volume: 70, Issue:4 Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Female; Humans; Male; Meloxicam; Middle Aged; Respiratory Hypersensitivity; Respiratory Tract Diseases; Retrospective Studies	2022